REFERENCES
1. Lee H, Jang HC, Park HK, Cho NH. Early manifestation of
cardiovascular disease risk factors in offspring of mothers with
previous history of gestational diabetes mellitus. Diabetes Res Clin
Pract 2007;78:238-45.
2. Yu Y, Arah OA, Liew Z, Cnattingius S, Olsen J, Sørensen HT, et al.
Maternal diabetes during pregnancy and early onset of cardiovascular
disease in offspring: population based cohort study with 40 years of
follow-up. BMJ 2019;367:l6398
3. Aguilera J, Semmler J, Coronel C, Georgiopoulos G, Simpson J,
Nicolaides KH, et al. Paired maternal and fetal cardiac functional
measurements in women with gestational diabetes mellitus at 35-36 weeks’
gestation. Am J Obstet Gynecol 2020;9378:30467-1
4. Miranda JO, Cerqueira RJ, Ramalho C, Areias JC, Henriques-Coelho T.
Fetal cardiac function in maternal diabetes: a conventional and
speckle-tracking echocardiographic study. J Am Soc Echocardiogr
2018;31:333-41.
5. Patey O, Carvalho JS, Thilaganathan B. Perinatal changes in fetal
cardiac geometry and function in diabetic pregnancy at term. Ultrasound
Obstet Gynecol 2019;54:634-42.
6. Mehta S, Nuamah I, Kalhan S. Altered diastolic function in
asymptomatic infants of mothers with gestational diabetes. Diabetes
1991;40:56-60.
7. Walker J. NICE guidance on diabetes in pregnancy: management of
diabetes and its complications from preconception to the postnatal
period. NICE clinical guideline 63. London, March 2008. Diabet Med
2008;25:1025-7.
8. Nicolaides K, Wright D, Syngelaki A, Wright A, Akolekar R. Fetal
Medicine Foundation fetal and neonatal population weight charts.
Ultrasound Obstet Gynecol 2018;52:44-51.
9. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al.
Guidelines and standards for performance of a pediatric echocardiogram:
a report from the Task Force of the Pediatric Council of the American
Society of Echocardiography. J Am Soc Echocardiogr 2006;19:1413-30.
10. Mohsin M, Sadqani S, Younus K, Hoodbhoy Z, Ashiqali S, Atiq M.
Evaluation of cardiac function in fetuses of mothers with gestational
diabetes. Cardiol Young 2019;29:1264-7.
11. Rolf N, Kerschke L, Braun J, Falkenberg MK, Hammer K, Köster HA, et
al. Quantification of fetal myocardial function in pregnant women with
diabetic diseases and in normal controls using speckle tracking
echocardiography (STE). J Perinat Med 2018;47:68-76.
12. Fouda UM, Abou ElKassem MM, Hefny SM, Fouda RM, Hashem AT. Role of
fetal echocardiography in the evaluation of structure and function of
fetal heart in diabetic pregnancies. J Matern Fetal Neonatal Med
2013;26:571-5.
13. Hatém MAB, Zielinsky P, Hatém DM, Nicoloso LH, Manica JL, Piccoli
AL, et al. Assessment of diastolic ventricular function in fetuses of
diabetic mothers using tissue Doppler. Cardiology in the Young
2008;18:297-302.
14. DeVore GR, Polanco B, Satou G, Sklansky M. Two‐dimensional speckle
tracking of the fetal heart: a practical step‐by‐step approach for the
fetal sonologist. J Ultrasound Med 2016;35:1765-81.
15. Patey O, Carvalho JS, Thilaganathan B. Intervendor Discordance of
Fetal and Neonatal Myocardial Tissue Doppler and Speckle-Tracking
Measurements. J Am Soc Echocardiogr 2019;32:1339-49. e23.
16. Ghandi Y, Habibi D, Nasri K, Alinejad S, Taherahmad H, Arjmand
Shabestari A, et al. Effect of well-controlled gestational diabetes on
left ventricular diastolic dysfunction in neonates. J Matern Fetal
Neonatal Med 2019;32:2101-6.
17. Zablah JE, Gruber D, Stoffels G, Cabezas EG, Hayes DA. Subclinical
decrease in myocardial function in asymptomatic infants of diabetic
mothers: A tissue Doppler study. Pediatr Cardiol 2017;38:801-6.
18. Touozaki T, Hiroe M, Hasumi M, Horie T, Hosoda S, Tsushima T, et al.
Insulin-like growth factor I receptors in human cardiac myocytes and
their relation to myocardial hypertrophy. Jpn Circ J 1993;57:1120-7.
19. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus
insulin for the treatment of gestational diabetes. N Engl J Med
2008;358:2003-15.
20. Hanem LGE, Salvesen Ø, Juliusson PB, Carlsen SM, Nossum MCF, Vaage
MØ, et al. Intrauterine metformin exposure and offspring cardiometabolic
risk factors (PedMet study): a 5–10 year follow-up of the PregMet
randomised controlled trial. Lancet Child Adolesc Health 2019;3:166-74.
21. Panagiotopoulou O, Syngelaki A, Georgiopoulos G, Simpson J, Akolekar
R, Shehata H, et al. Cardiometabolic Follow Up of the Offspring From the
Metformin in Obese Non-Diabetic Pregnant (MOP) Women Trial. Am J Obstet
Gynecol 2020; 9378:30109-5.
22. Chen C, Gui YH, Ren YY, Shi LY. The impacts of maternal gestational
diabetes mellitus (GDM) on fetal hearts. Biomed Environ Sci
2012;25:15-22.
23. Escobar J, Teramo K, Stefanovic V, Andersson S, Asensi MA, Arduini
A, et al. Amniotic fluid oxidative and nitrosative stress biomarkers
correlate with fetal chronic hypoxia in diabetic pregnancies.
Neonatology 2013;103:193-8.
24. Levkau B, Schafers M, Wohlschlaeger J, von Wnuck Lipinski K, Keul P,
Hermann S, et al. Survivin determines cardiac function by controlling
total cardiomyocyte number. Circulation 2008;117:1583-93.
25. Song Q, An X, Li D, Sodha NR, Boodhwani M, Tian Y, et al.
Hyperglycemia attenuates angiogenic capability of survivin in
endothelial cells. Microvascular research 2009;78:257-64.
26. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al.
Transient high glucose causes persistent epigenetic changes and altered
gene expression during subsequent normoglycemia. J Exp Med
2008;205:2409-17.